Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Trading Update

21 Aug 2023 07:00

RNS Number : 8881J
Crest Nicholson Holdings PLC
21 August 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018

 

Crest Nicholson Holdings plc

(the "Group" or "Crest Nicholson")

 

TRADING UPDATE

FY23 ADJUSTED PROFIT BEFORE TAX NOW EXPECTED TO BE AROUND £50.0m

 

Trading Environment

Against a backdrop of persistently high inflation and rising interest rates, trading conditions for the housing market have worsened during the summer of this year. While pricing has remained resilient in a market with limited supply and few distressed sellers, the economic uncertainty is deterring prospective home movers. Additional mortgage borrowing for those looking to upgrade or for those with low levels of equity, notably first-time buyers, has become significantly more expensive with no Government support (following the end of Help to Buy) now in place to cushion this impact.

Transaction levels across the industry have therefore weakened further, particularly in recent weeks. Although overall inflation is encouragingly starting to fall, core inflation and wage inflation both remain high with further interest rate rises forecast over the coming months. The Group does not therefore expect to see a material improvement in trading conditions before its year end at 31 October 2023.

At the interim results in June 2023 the Group outlined that it was forecasting a SPOW rate of 0.50 for the second half and for the 7 weeks to 18 August 2023 this has been 0.25, representing a progressively deteriorating trend.

Given this market backdrop the Group is also currently negotiating several bulk deals on appropriate commercial terms with partners where it has developed strong relationships over recent years. These transactions will provide support to volume delivery in future years.

Legacy Schemes

In addition to a poorer trading environment, the Group has also recorded a further £4.0m cost movement in the second half at Brightwells Yard, Farnham. This site is a highly complex urban regeneration and mixed-use development scheme with a build programme expected to conclude by the end of the calendar year.

Management Actions

Management are responding proactively to these conditions. The Group was able to add several high-quality sites to the land portfolio in the first half and, as has been previously communicated, expects future land activity to reduce significantly.

Management will also be reducing the Group's overhead position in the next financial year and will be incorporating the newly created East Anglia division into its existing Eastern division with revised boundaries. Yorkshire will remain unaffected given it is now a fully operational division, but the pace of growth and onboarding of further resources expected in this region will be revised to reflect the market conditions. Further detail on these initiatives will be shared in the Group's November trading update.

Dividend

The Board remains committed to the FY23 dividend pence per share in line with prior year at 17.0 pence per share as announced in June 2023.

Outlook

The Board remains positive and confident about the outlook for Crest Nicholson. While the current trading conditions are challenging, over the medium term it expects inflation to abate and mortgage rates start to reduce. In addition, the Group has a strong financial position and an experienced leadership team who are used to trading through downturns in the cycle. The long-term structural shortfall of housing supply versus demand continues to increase and the Group has developed an attractive land portfolio.

Reflecting the factors outlined above, the Group now expects FY23 Adjusted Profit Before Tax to be around £50.0m.

Analyst and investor conference call

There will be a brief conference call for analysts at 9.00 am today hosted by Peter Truscott, Chief Executive and Duncan Cooper, Group Finance Director.

Dial in details:

UK: 0207 660 8380

Toll-free: 0800 029 3426

Phone Conference ID: 924 858 743#

 

For further information, please contact:

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

Teneo Communications

James Macey White / Giles Kernick +44 (0) 20 7353 4200

 

The person responsible for arranging the release of this announcement on behalf of the Company is Harriet Huband, Interim Company Secretary.

21 August 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFLLTSIIFIV
Date   Source Headline
29th May 202610:34 amRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
21st May 20269:52 amRNSHolding(s) in Company
20th May 20262:28 pmRNSHolding(s) in Company
19th May 20267:00 amRNSRevised date for the half year results
12th May 20262:09 pmRNSDirector/PDMR Shareholding
1st May 20264:26 pmRNSHolding(s) in Company
30th Apr 20264:04 pmRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
28th Apr 20262:56 pmRNSDirector/PDMR Shareholding
24th Apr 20264:47 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSTrading Update
20th Apr 20265:21 pmRNSHolding(s) in Company
10th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20269:57 amRNSAdmission to Trading
31st Mar 20263:23 pmRNSTotal Voting Rights
26th Mar 20263:24 pmRNSDirector/PDMR Shareholding
25th Mar 202611:59 amRNSResult of AGM
25th Mar 20267:00 amRNSTrading Statement
24th Mar 20268:45 amRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:22 pmRNSDirector/PDMR Shareholding
27th Feb 20262:37 pmRNSTotal Voting Rights
17th Feb 202610:38 amRNSAnnual Report & Notice of AGM
10th Feb 20265:04 pmRNSDirector/PDMR Shareholding
30th Jan 20262:11 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSFinal Results
12th Jan 20265:02 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:46 pmRNSTotal Voting Rights
23rd Dec 20253:46 pmRNSTotal Voting Rights
10th Dec 20254:07 pmRNSDirector/PDMR Shareholding
5th Dec 202510:22 amRNSDirector Declaration
28th Nov 20252:55 pmRNSTotal Voting Rights
19th Nov 202512:59 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSTrading Statement
11th Nov 202512:32 pmRNSDirector/PDMR Shareholding
5th Nov 202510:40 amRNSHolding(s) in Company
31st Oct 20255:07 pmRNSTotal Voting Rights
28th Oct 202511:06 amRNSHolding(s) in Company
28th Oct 202510:02 amRNSDirectorate Change
24th Oct 20253:05 pmRNSHolding(s) in Company
17th Oct 202510:08 amRNSBlock listing Interim Review
10th Oct 20254:21 pmRNSDirector/PDMR Shareholding
30th Sep 202512:07 pmRNSTotal Voting Rights
22nd Sep 20252:48 pmRNSHolding(s) in Company
11th Sep 20254:07 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:48 pmRNSHolding(s) in Company
29th Aug 20251:28 pmRNSTotal Voting Rights
13th Aug 20259:58 amRNSDirector/PDMR Shareholding
1st Aug 20254:46 pmRNSHolding(s) in Company
31st Jul 20252:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.